Exposures to Environmental Toxicants and Attention Deficit Hyperactivity Disorder in U.S. Children by Braun, Joe M. et al.
1904 VOLUME 114 | NUMBER 12 | December 2006 • Environmental Health Perspectives
Research | Children’s Health
Attention deficit hyperactivity disorder
(ADHD) is one of the most common child-
hood disorders, with an estimated prevalence
ranging from 3 to 8% [American Psychiatric
Association (APA) 1994; Costello et al. 2003;
Lesesne et al. 2003; Olfson et al. 2003; Pastor
and Reuben 2002; Rowland et al. 2002;
Wolraich et al. 1996]. Children who have
ADHD are at increased risk for conduct dis-
order, antisocial behavior, and drug abuse
later in life (Costello et al. 2003; Mannuzza
1993). Moreover, the costs associated with
their medical care and education are substan-
tial (Leibson et al. 2001). Although the mech-
anisms for the development of ADHD remain
unclear, both genetic and environmental fac-
tors have been implicated (Ernst et al. 2001). 
Numerous studies have found a signiﬁcant
association between prenatal environmental
tobacco smoke (ETS) exposure and ADHD or
ADHD-related behaviors, even after control-
ling for postnatal ETS exposures and familial
psychopathology (Day et al. 2000; Fergusson
et al 1993b; Kotimaa et al. 2003; Leech et al.
1999; Mick et al. 2002a; Milberger et al. 1996,
1998; Thapar et al. 2003; Wasserman et al.
2001; Williams et al. 1998). In case–control
studies, investigators have found a 2- to 4-fold
increased risk for ADHD associated with pre-
natal ETS exposure (Mick et al. 2002a;
Milberger et al. 1996, 1998). In contrast, the
relationship between postnatal ETS exposure
and children’s behavior problems has not been
fully elucidated (Day et al. 2000; Fergusson
et al 1993b; Weitzman et al. 1992; Williams
et al. 1998). Moreover, the attributable frac-
tion of childhood ADHD due to ETS expo-
sure is unknown. 
Environmental lead exposure, measured in
blood or dentin, has been associated with
higher rates of inattention and impulsivity
(Bellinger et al. 1994; Fergusson et al. 1993a;
Needleman et al. 1979; Wasserman et al.
1998, 2001). Although lead exposure is often
cited as a risk factor for ADHD, existing stud-
ies examining the association of lead exposure
with a diagnosis of ADHD, which were lim-
ited by small sample size, are inconclusive
(David et al. 1972; Gittleman and Eskenazi
1983). Moreover, many of the studies examin-
ing the association of lead exposure with inat-
tention or impulsivity involved children who
had higher blood lead levels than the levels
seen in contemporary children, and thus may
not be directly relevant to children with lower
levels of lead exposure (Bellinger et al. 1994;
Needleman et al. 1979; Fergusson et al. 1993a;
Wasserman et al. 1998, 2001). Although sev-
eral recent studies have linked lead to IQ
deficits at blood lead levels < 10 µg/dL
(Bellinger and Needleman 2003; Canfield
et al. 2003; Lanphear et al. 2005)—the current
action level set by the Centers for Disease
Control and Prevention (CDC)—it remains
unclear whether blood lead levels < 10 µg/dL
are also associated with behavioral problems in
children (CDC 2005b). 
Studies investigating the effect of environ-
mental exposures on neurobehavioral out-
comes have been complicated by evidence
from both animal and human studies that
toxicants may have differing effects in male
and female subjects (Burns et al. 1999; Ernst
2001; McCartney 1999; O’Callaghan et al.
1992; Ribary and Lichtensteiger 1989; Ris
et al. 2004; Weissman et al. 1999). The
prevalence of ADHD is three times greater
among males than among females (Costello
et al. 2003; Lesesne et al. 2003; Olfson et al.
2003; Pastor and Reuben 2002). Some stud-
ies have documented varying behavioral
effects of prenatal ETS exposure in males and
females (Fergusson et al. 1998; Weissman
et al. 1999), whereas other studies have not
(Mick et al. 2002a; Milberger et al. 1996,
1998; Orlebeke et al. 1999). Studies of lead
exposure’s effects have been similarly compli-
cated: There is some evidence that males are
at increased risk for externalizing behaviors
(Burns et al. 1999) and attentional problems
(Ris et al. 2004) from lead exposure, but the
results are not entirely consistent. 
The purpose of this study was to explore
the relationship between exposure to ETS and
environmental lead with ADHD using a large
nationally representative sample of children.
We also explored whether sex modifies the
relationships between these neurotoxicants
and ADHD. Finally we provide estimates of
population attributable fraction of prenatal
ETS exposure and lead exposure for ADHD
in U.S. children. 
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OBJECTIVE: The purpose of this study was to examine the association of exposures to tobacco
smoke and environmental lead with attention deﬁcit hyperactivity disorder (ADHD). 
METHODS: Data were obtained from the National Health and Nutrition Examination Survey
1999–2002. Prenatal and postnatal tobacco exposure was based on parent report; lead exposure was
measured using blood lead concentration. ADHD was deﬁned as having current stimulant medica-
tion use and parent report of ADHD diagnosed by a doctor or health professional. 
RESULTS: Of 4,704 children 4–15 years of age, 4.2% were reported to have ADHD and stimulant
medication use, equivalent to 1.8 million children in the United States. In multivariable analysis,
prenatal tobacco exposure [odds ratio (OR) = 2.5; 95% confidence interval (CI), 1.2–5.2] and
higher blood lead concentration (ﬁrst vs. ﬁfth quintile, OR = 4.1; 95% CI, 1.2–14.0) were signiﬁ-
cantly associated with ADHD. Postnatal tobacco smoke exposure was not associated with ADHD
(OR = 0.6; 95% CI, 0.3–1.3; p = 0.22). If causally linked, these data suggest that prenatal tobacco
exposure accounts for 270,000 excess cases of ADHD, and lead exposure accounts for 290,000
excess cases of ADHD in U.S. children. 
CONCLUSIONS: We conclude that exposure to prenatal tobacco and environmental lead are risk factors
for ADHD in U.S. children. 
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Data source. The data for this analysis came
from the National Health and Nutrition
Examination Survey (NHANES), conducted
from 1999 to 2002. The NHANES is a cross-
sectional household survey of the noninstitu-
tionalized civilian population. NHANES
used a complex, multistage probability sam-
pling design, with oversampling of children
(< 5 years of age), Mexican Americans, and
non-Hispanic blacks (CDC 2002a). Details
regarding interviews, examination procedures,
and sample collection have been described
elsewhere (CDC 2002b).
Assessment of ADHD and exposures to
environmental toxicants. The primary depen-
dent variables that we used to assess ADHD
status were parent report of a diagnosis of
ADHD and stimulant medication use. Parent-
reported ADHD was based on the parent or
guardian’s response to the question “Has a
doctor or health professional ever told you that
your child had attention deﬁcit disorder?” To
improve the speciﬁcity of the diagnosis of par-
ent-reported ADHD, we used parent-reported
ADHD and stimulant medication use as the
main outcome. Stimulant medication use was
based on National Drug Codes 03700, 17900,
39500, and 82000 (CDC 2005a). These codes
correspond to amphetamine aspartate/amphet-
amine sulfate/dextroamphetamine aspartate/
dextroamphetamine sulfate, dextroampheta-
mine sulfate, methylphenidate hydrochloride,
and unspecified ADHD medication, respec-
tively. Children who had only stimulant med-
ication use or parent report of ADHD were
excluded from the primary analysis. Secondary
analyses investigated report of ADHD diagno-
sis and ADHD medication use as separate out-
comes to conﬁrm the validity of our primary
analysis results. 
We used parent report to measure
children’s exposure to tobacco products.
Measurement of prenatal ETS exposure con-
sisted of the question “Did the child’s biologi-
cal mother smoke at any time while she was
pregnant with him/her?” No information on
the quantity or brand of cigarettes smoked
during pregnancy was collected. We assessed
postnatal ETS exposure using parent-reported
exposure to household ETS by asking “Does
anyone who lives here smoke cigarettes, cig-
ars, or pipes anywhere inside this home?” In a
secondary analysis, we explored using the
child’s serum cotinine concentration, a
metabolite of nicotine, as a biomarker of ETS
exposure (Bernert et al 2000). All children
with cotinine values < 0.05 ng/mL were
imputed from the left tail of the log-normal
distribution using Cohen’s method (Cohen
1959). We focused primarily on reported
presence of a smoker in the home as the inde-
pendent variable because serum cotinine
values were missing for 921 children.
We determined blood lead concentration
by graphite furnace atomic absorption spec-
trophotometry (Miller et al. 1987; Parsons
and Slavin 1993). The limit of detection was
reported to be 0.3 µg/dL: 48 children had
blood lead levels below this threshold.
Nondetectable values were given values of 0.2
(0.3 divided by √2).
Covariates. We examined multiple covari-
ates and potential confounders for the associa-
tion of prenatal ETS exposure and lead
exposure with ADHD. Demographic variables
included the child’s age, sex, race, and socio-
economic status [as measured by poverty-to-
income ratio (PIR)]. PIR is the ratio of family
income to the poverty threshold for the year of
the interview. Children with PIR values < 1 are
considered to be living below the poverty level.
Health insurance coverage was also included as
a covariate. In addition, a review of the litera-
ture suggested that preschool attendance, low
birth weight, and ferritin levels (an indicator of
iron status) should be considered potential
confounders because of their prior docu-
mented associations with child behavioral
problems and environmental toxicants
[Knopik et al. 2005; Kordas et al. 2004; Mick
2002b; National Institute of Child Health and
Human Development (NICHD) 2003; St.
Sauver et al. 2004; Wasserman et al. 2001].
Child’s birth weight and admission to a neona-
tal intensive care unit (NICU) were included
as markers of perinatal distress.
Statistical analysis. We used logistic regres-
sion analysis with a binary outcome of ADHD
to identify predictors of ADHD. Variables
found to be associated with ADHD based on
chi-square (p < 0.2) in bivariable analyses were
included in the logistic regression analyses.
Postnatal ETS exposure was forced into all
multivariable models. Because NICU admis-
sion and birth weight may be acting as inter-
vening variables on the pathway from prenatal
ETS exposure to ADHD, we included these
two variables in secondary analyses to examine
whether their inclusion altered our findings
(Kiely 1991). We also examined the relation-
ship of lead exposure and ADHD at blood lead
levels ≤ 5 µg/dL in secondary analyses. 
Among children 4–15 years of age, 5,171
were available for analysis. We found that chil-
dren who did not have routine access to health
care were unlikely to be treated with stimulant
medications; therefore, we excluded these chil-
dren from the main analysis (n = 458).
Regression diagnostics were conducted to iden-
tify influential observations and collinearity.
Influential observations were excluded from
analyses to examine whether their inclusion
altered the results (n = 9). The exclusion of
these outliers did not signiﬁcantly inﬂuence the
estimates of prenatal ETS exposure or environ-
mental lead exposure. After excluding outliers
and children without routine access to health
care, 4,704 children were available for bivariate
analyses; of those children, 3,879 had complete
data available for multivariate analyses.
After developing a multivariable main
effects model, we tested for an interaction
between sex and prenatal ETS exposure, and
between sex and blood lead concentration. For
prenatal ETS exposure, we first analyzed the
complete sample and modeled the potential
interaction using a variable with four cate-
gories: unexposed females (reference category),
exposed females, unexposed males, and
exposed males (Rothman 2002). We also
tested whether a formal sex-by-exposure inter-
action term was statistically significant for
blood lead concentration and prenatal
ETS exposure. We calculated population-
attributable fraction (PAF) for risk factors
independently associated with ADHD using
Miettinen’s formula (Hanley 2001). Because
these independent risk factors are not mutually
exclusive of other risk factors, we also estimated
the PAF of children having either environ-
mental lead and prenatal ETS exposures. 
Analyses were performed using the
SUDAAN statistical package to account for the
multistage, complex sampling design (Research
Triangle Institute 2004). Sample weights
were applied according to the National
Center for Health Statistics guidelines (CDC
2004) to produce accurate national estimates,
adjusting for the oversampling of minorities
and young children. 
This study was approved by the National
Center for Health Statistics Institutional
Review Board, Cincinnati Children’s Hospital
Medical Center Institutional Review Board,
and the University of Milwaukee College of
Nursing Institutional Review Board. Consent
was obtained from all participants.
Results
Of the 4,704 eligible children 4–15 years of
age, 344 (8.2%) had only parent-reported
ADHD and 154 (4.3%) reported stimulant
medication use, equivalent to 3.8 million and
2.0 million U.S. children and adolescents,
respectively. Of the 4,704 children, 135
(4.2% weighted percent) had parent report of
both ADHD and stimulant medication use,
equivalent to 1.8 million children in the
United States. (Table 1). In bivariate analyses,
we found a significant association between
parent-reported ADHD and stimulant med-
ication use with prenatal ETS exposure (p =
0.023), preschool attendance (p = 0.003),
male sex (p < 0.001), increasing age in years
(p < 0.001), and health insurance coverage
(p < 0.001) (Table 1). Non-Hispanic white
children were more likely than other racial
groups to report ADHD (p = 0.001). 
In multivariable analysis, prenatal ETS
exposure and blood lead concentration were
significant predictors of ADHD (Table 2).
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ETS exposure was 2.5 [95% conﬁdence inter-
val (CI), 1.2–5.2]. We also found a signiﬁcant
dose–response relationship between lead expo-
sure and ADHD (Figure 1). Compared with
children in the lowest quintile of blood lead
concentration, children with blood lead levels
in the fifth quintile (AOR = 4.1; 95% CI,
1.2–14.0) were at signiﬁcantly higher risk for
ADHD. The risk of ADHD was also signiﬁ-
cantly associated with male sex (AOR = 3.7;
95% CI, 2.1–6.6). Mexican-American and
non-Hispanic black children had lower risks
for reported ADHD diagnosis and stimulant
medication use (AOR = 0.3; 95% CI, 0.1–0.7
and AOR = 0.5; 95% CI, 0.3–0.8, respec-
tively) compared with non-Hispanic white
children. Postnatal ETS exposure, as measured
by the presence of a smoker in the home, was
not a signiﬁcant predictor of ADHD status in
adjusted models (AOR = 0.6; 95% CI,
0.3–1.3; p = 0.224). The risk for ADHD was
signiﬁcantly associated with preschool atten-
dance (AOR = 2.4; 95% CI, 1.1–5.1).
Next, we tested for interactions between sex
and prenatal exposure to ETS, sex and blood
lead concentration, and prenatal exposure to
ETS and blood lead concentration. We did not
ﬁnd a signiﬁcant interaction between prenatal
ETS exposure and sex using a formal inter-
action term (p = 0.141). Compared with
unexposed females, females who were pre-
natally exposed to ETS were at a 4.6-fold
higher risk for ADHD compared with
unexposed females (OR = 4.6; 95% CI,
1.7–12.4), whereas exposed males were at an
almost significant 2-fold higher risk for
ADHD than unexposed males (OR = 2.1;
95% CI, 0.9–4.7; p = 0.073) (Figure 2). There
was not a signiﬁcant interaction between blood
lead levels by sex (p = 0.242) or blood lead
levels by maternal smoking (p = 0.837). 
We conducted secondary analyses to
examine the effects of lead exposure at blood
lead levels < 5 µg/dL and to test the stability of
our results. When the sample was restricted to
children with concurrent blood lead concen-
trations ≤ 5 µg/dL, there was still a signiﬁcant
association between higher blood lead levels
and ADHD. Compared with children in the
lowest quintile (nondetectable to 0.7 µg/dL),
children with blood lead levels in the highest
quintile (2.0–5 µg/dL) had a 4.5-fold (95%
CI, 1.3–15.3) higher risk for ADHD. 
When birth weight and NICU were added
to the primary model, the adjusted OR for
prenatal ETS exposure and the ﬁfth quintile of
blood lead levels did not change, remaining at
2.2 (95% CI, 1.0–5.1; p = 0.055) and 4.5
(95% CI, 1.3–15.6; p = 0.019), respectively.
Consistent with postnatal ETS exposure meas-
ured by parent report, postnatal ETS exposure
using serum cotinine was not associated with
ADHD (AOR = 0.99; 95% CI, 0.97–1.00;
p = 0.092). Using the same multivariable
model, we found that when the ADHD out-
come was deﬁned simply by parent report or
by stimulant medication use, rather than the
combination of the two, the AOR of maternal
smoking and blood lead level did not differ
appreciably. Finally, there was no substantive
change in the relationship of either prenatal
ETS exposure or blood lead concentration
when we included children without routine
access to health care in the model. 
The PAF for prenatal ETS exposure for
both males and females was 18.4% (95% CI,
5.1–24.8%), corresponding to 270,000 cases
of ADHD in children 4–15 years of age
(Table 3). Although there was a significant
dose–response relationship between lead expo-
sure and ADHD, we estimated the population
attributable fraction only for children who had
blood lead levels in the ﬁfth quintiles of blood
lead concentration. Our estimates indicate
that 21.1% (95% CI, 4.6–25.9%) of ADHD
Braun et al.
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Table 1. Prevalence of stimulant medication use and parent-reported ADHD among children 4–15 years of
age in NHANES 1999–2002 according to demographic and medical factors. 
Weighted percent of parent-reported ADHD 
Variable Sample size (n) with prescription stimulant use (95% CI) p-Valuea
Total 4,704 4.2 (3.3–5.3)
Age (years) < 0.001
4–6 1,018 1.0 (0.4–2.4)
7–9 1,003 4.8 (3.3–7.0)
10–12 1,182 6.5 (4.5–9.2)
13–15 1,501 4.5 (2.4–8.2)
Sex < 0.001
Male 2,264 6.6 (5.1–8.5)
Female 2,440 1.8 (1.2–2.9)
Race 0.001
Mexican American 1,519 1.0 (0.6–1.9)
Other Hispanic 218 3.1 (1.4–6.8)
Non-Hispanic white 1,293 5.5 (4.1–7.2)
Non-Hispanic black 1,493 3.1 (2.2–4.4)
Other, including multiracial 181 1.1 (0.3–4.1)
PIR 0.639
1st quartile (0–1.04) 1,434 5.7 (3.6–8.9)
2nd quartile (1.05–2.08) 1,121 3.6 (2.3–5.3)
3rd quartile (2.09–3.73) 916 4.5 (2.6–7.7)
4th quartile (3.74–5.0) 789 3.8 (2.7–5.5)
Prenatal ETS exposure 0.023
No 4,014 3.4 (2.6–4.5)
Yes 616 7.3 (4.8–11.2)
Smoker in the home 0.210
No 3,669 3.9 (3.0–4.9)
Yes 980 5.6 (3.5–9.1)
Lead quintiles (µg/dL) 0.190
1st quintile (ND–0.7) 679 2.1 (0.9–4.7)
2nd quintile (0.8–1.0) 795 3.4 (1.4–7.7)
3rd quintile (1.1–1.3) 857 5.0 (3.6–6.9)
4th quintile (1.4–2.0) 745 4.7 (3.1–6.9)
5th quintile (≥ 2.0) 995 5.2 (2.9–8.9)
NICU 0.504
No 4,129 4.0 (3.2–5.1)
Yes 532 4.9 (2.9–8.2)
Attended preschool 0.003
No 1,518 2.4 (1.3–4.5)
Yes 3,178 4.8 (3.8–6.1)
Covered by health insurance < 0.001
No 630 0.2 (0.1–0.9)
Yes 4,011 4.7 (3.7–6.0)
Ferritin (ng/mL) 0.107
1st quartile (< 20) 965 2.7 (1.3–5.5)
2nd quartile (20–29) 1,073 3.7 (2.5–5.5)
3rd quartile (30–42) 955 3.8 (2.1–6.9)
4th quartile (> 42) 1,017 7.7 (5.2–11.3)
Birth weight 0.905
≥ 2,500 g 4,258 4.2 (3.3–5.4)
< 2,500 g 393 4.0 (1.7–9.1)
Cotinine tertiles (imputed) (ng/mL) 0.322
1st tertile (< 0.028) 1,288 3.4 (2.4–4.9)
2nd tertile (0.028–0.259) 1,348 4.5 (2.7–7.6)
3rd tertile (> 0.260) 1,183 5.8 (3.7–9.1)
ND, Not detectable.
aOverall p-value for the variable. cases among children 4–15 years of age were
attributable to having a blood lead
> 2.0 µg/dL. This corresponds to 290,000
excess cases of ADHD among U.S. children
4–15 years of age (Table 3). Finally, we calcu-
lated the PAF for having either prenatal ETS
exposure or blood lead concentration > 2.0
µg/dL to account for children who had both
exposures. Our estimates indicate that 32.2%
(95% CI, 4.2–41.3%) of ADHD cases among
children 4–15 years of age were attributable to
having either prenatal ETS exposure or blood
lead > 2.0 µg/dL, which corresponds to
480,000 excess cases of ADHD among U.S.
children 4–15 years of age. 
Discussion
Overall, 4.2% of children surveyed had par-
ent-reported ADHD and were taking stimu-
lant medication, equivalent to approximately
1.8 million U.S. children in the 4- to 15-year-
old population. This rate is consistent with
previous estimates of ADHD prevalence,
which have ranged from 3 to 8% (APA 1994;
Lesesne et al. 2003; Olfson 2003; Pastor and
Reuben 2002). Our analysis confirms prior
studies linking prenatal ETS exposure with
ADHD and, for the ﬁrst time, demonstrates a
signiﬁcant dose–response relationship between
childhood lead exposure and ADHD. In con-
trast, we did not ﬁnd a signiﬁcant association
between postnatal ETS exposure and ADHD. 
In this sample, the overall adjusted risk for
ADHD was 2.5-fold higher for children
exposed prenatally to ETS, which is consistent
with previous case–control studies (Mick et al.
2002a; Milberger et al. 1996, 1998). Previous
studies using large cohorts have reported a 1.5-
to 2.0-fold increase in risk for behavior prob-
lems among children whose mothers smoked
during pregnancy, but they did not speciﬁcally
examine ADHD status (Fergusson et al.
1993b; Weitzman et al. 1992; Williams et al.
1998). Using a large national sample, we con-
ﬁrmed that prenatal ETS exposure was a strong
risk factor for ADHD, especially for females. 
Although the difference in risks by sex
was not statistically significant, these results
suggest that females may be more susceptible
to tobacco-associated ADHD. Females
exposed prenatally to ETS had a 4.6-fold
increased risk of ADHD compared with
unexposed females, whereas males exposed
prenatally to ETS were at a 2.1-fold increased
risk for ADHD compared with unexposed
males. When females are exposed prenatally
to ETS, their risk of ADHD becomes equiva-
lent to that of unexposed males. 
Postnatal ETS exposure was not associ-
ated with ADHD in this analysis. We used
parent report of household ETS and serum
cotinine, but neither was associated with par-
ent-reported ADHD. In previous research,
investigators found a signiﬁcant association of
current tobacco consumption of the mother
and externalizing behavior problems in chil-
dren using continuous measures of behavior
(Day et al. 2000; Weitzman et al. 1992;
Williams et al 1998). It is possible that our
results differ because we used a dichotomous
outcome measure, thus limiting our sensitiv-
ity to detect an association between postnatal
ETS exposure and ADHD-related behavior
problems. Furthermore, the cross-sectional
measures of reported postnatal ETS exposure
and serum cotinine levels may have failed to
detect postnatal ETS exposure at critical times
in development that may be associated with
ADHD or ADHD-related behaviors.
We found a signiﬁcant dose–response rela-
tionship of higher blood lead levels and
ADHD. Compared with the lowest quintile of
blood lead levels, children with blood lead lev-
els > 2.0 µg/dL were at a 4.1-fold increased
risk of ADHD. When we limited the analysis
to children with blood lead levels ≤ 5 µg/dL,
the association between increased blood lead
levels and ADHD remained. These results are
consistent with previous reports that have
found signiﬁcant associations between blood
or dentin lead levels and behavior problems
Environmental toxicant exposures and ADHD
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Table 2. Logistic regression analysis for parent-reported attention deficit disorder among children 4–15
years of age, NHANES 1999–2002.a
AOR for parent-reported ADHD 
Variable with prescription stimulant use (95% CI) p-Value
Age (years) 1.1 (1.0–1.2) 0.016
Sex
Female Referent
Male 3.7 (2.1–6.6) < 0.001
Race
Non-Hispanic white Referent
Other Hispanic 0.5 (0.1–2.1) 0.322
Mexican American 0.3 (0.1–0.7) 0.005
Non-Hispanic black 0.5 (0.3–0.8) 0.012
Other, including multiracial 0.2 (0.03–1.2) 0.072
Prenatal ETS exposure
No Referent
Yes 2.5 (1.2–5.2) 0.020
Smoker in the home
No Referent
Yes 0.6 (0.3–1.3) 0.224
Lead quintiles (µg/dL)
1st quintile (ND–0.7) Referent
2nd quintile (0.8–1.0) 1.1 (0.4–3.4) 0.804
3rd quintile (1.1–1.3) 2.1 (0.7–6.8) 0.195
4th quintile (1.4–2.0) 2.7 (0.9–8.4) 0.086
5th quintile (> 2.0) 4.1 (1.2–14.0) 0.026
Preschool/child care attendance
No Referent
Yes 2.4 (1.1–5.1) 0.022
Covered by health insurance
No Referent
Yes 18.9 (3.7–97.4) 0.001
Ferritin (ng/mL) 1.006 (0.999–1.013) 0.089
ND, not detectable.
aModel adjusted for age, sex, race, prenatal ETS exposure, postnatal ETS exposure, blood lead levels, preschool or child
care attendance, health insurance coverage, and ferritin levels. 
Figure 1. AOR for ADHD among U.S. children,
NHANES 1999–2002, by blood lead concentration
(µg/dL). The model was adjusted for child’s age,
sex, race/ethnicity, preschool attendance, serum
ferritin, prenatal ETS exposure, smoker in the
household, and insurance status.
p-value for trend = 0.012.











Figure 2. AOR for ADHD among U.S. children by
prenatal ETS exposure and sex. The risk for ADHD
among ETS-exposed children was greater in
females; females who were prenatally exposed to
tobacco were at 4.6-fold higher risk for ADHD com-
pared with unexposed females (OR = 4.6; 95% CI,
1.7–12.4), whereas exposed males were at 2-fold
higher risk for ADHD compared with unexposed
males (OR = 2.1; 95% CI, 0.9–4.7) (p = 0.141 for sex
by prenatal ETS exposure interaction). Model
adjusted for race/ethnicity, sex, age, blood lead
level, ferritin level, presence of a smoker in the































Exposed(Bellinger et al. 1994; Fergusson et al. 1993a;
Sood et al. 2001; Wasserman et al. 1998,
2001). Our results further indicate that blood
lead levels below the CDC action level of 10
µg/dL are associated with an increased risk for
ADHD in children (CDC 2005b). This result
is consistent with previous studies that have
found cognitive deﬁcits in children with blood
lead levels < 10 µg/dL (Canﬁeld et al. 2003;
Lanphear et al. 2000, 2005). 
An interesting ﬁnding in this study was the
increased likelihood of ADHD for children
who attended preschool or child care.
Presumably, children who attend preschool or
child care are more likely to have problem
behaviors noted by staff, thus increasing their
chance for referral and diagnosis of ADHD by
a health professional. Results from the NICHD
child care study also suggest that children who
are more aggressive and disobedient are more
likely to be placed in child care at younger ages
and for longer periods of time (NICHD 2003).
Regardless of the reason for this ﬁnding, staff at
these facilities may play an important role in
identifying and referring children with behavior
problems for early intervention. 
This study has several limitations. First,
the cross-sectional nature of our data makes it
difﬁcult to infer a causal relationship from our
observed associations. Second, although some
might argue that concurrent blood lead tests
are not an adequate biomarker of a child’s life-
time exposure, recent studies indicate that
concurrent blood lead level is a stronger pre-
dictor of lead-associated IQ decrements than
blood lead measured during early childhood
(Chen et al. 2005; Lanphear et al. 2005). Still,
the stronger association between neurodevel-
opment and concurrent lead exposure has
been observed only within cognitive domains
and not behavioral domains. Third, although
we were able to adjust for many important
covariates and potential confounders, we were
unable to adjust for others, such as maternal
alcohol use during pregnancy and parental
psychopathology. 
An additional limitation of our cross-sec-
tional data is susceptibility to recall bias.
Mothers of children with behavior problems
may be more likely to recall gestational intake
of potentially harmful substances, such as
tobacco, owing to a drive to identify a cause of
their child’s disorder. On the other hand,
mothers may fail to report tobacco use during
pregnancy due to guilt or social stigma (i.e.,
social desirability bias). The reliance of our
outcome variable on parent report is also a
potential limitation. Nevertheless, by combin-
ing parent report of ADHD with stimulant
medication use for our main outcome, we
maximized the likelihood that all children
counted as ADHD cases had been evaluated
and diagnosed by a medical professional. On
the other hand, these criteria required us to
limit our analyses to children with routine
access to health care services. Excluding chil-
dren without routine access to health care
enhances the specificity of the diagnosis of
ADHD, but it also likely underestimates the
total number of ADHD cases that are attrib-
utable to prenatal ETS exposure and environ-
mental lead exposure. 
Using a dichotomous measure of ADHD
is less preferable than the administration of a
DSM (Diagnostic and Statistical Manual of
Mental Disorders)-based ADHD diagnostic
instrument, which would offer increased speci-
ﬁcity to detect behavior problems and speciﬁc
ADHD subtypes, as well as the possibility of
behavioral symptom counts. More continuous
measures of ADHD symptoms or of speciﬁc
underlying neurobehavioral domains may be
the most powerful way to detect lead and
tobacco effects, because ADHD may represent
the tail of a continuum of behavioral effects
produced by environmental chemical expo-
sures and other etiologic factors (Mercugliano
1999). However, due to the considerable time
and cost involved in the administration of
DSM-based diagnostic instruments, previous
national estimates of ADHD, such as the pre-
sent investigation, have relied on medication
use or parent report as measures of ADHD sta-
tus (APA 1994; Lesesne et al. 2003; Olfson
2003; Pastor and Reuben 2002).
This study confirms the previously
observed association of prenatal ETS exposure
and ADHD. We also found a significant
dose–response relationship between child-
hood lead exposure and ADHD. This analysis
indicates that 270,000 ADHD cases in chil-
dren 4–15 years of age are attributable to pre-
natal ETS exposure, and 290,000 cases of
ADHD among U.S. children 4–15 years of
age are attributable to environmental lead
exposure. The findings of this study under-
score the profound behavioral health impact
of these prevalent exposures, and highlight
the need to strengthen public health efforts to
reduce prenatal ETS exposure and childhood
lead exposure. 
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